[
{"ticker": "IPCI", "drug": "Rexista", "stage": "PDUFA", "date": "09/25/2017"},
{"ticker": "PRQR", "drug": "QR-010", "stage": "Phase 1b", "date": "09/25/2017"},
{"ticker": "PTCT", "drug": "Translarna", "stage": "PDUFA", "date": "09/28/2017"},
{"ticker": "NVO", "drug": "Fast-acting insulin aspart", "stage": "PDUFA", "date": "09/29/2017"},
{"ticker": "ABUS", "drug": "ARB-1467", "stage": "Phase 2", "date": "09/30/2017"},
{"ticker": "AXON", "drug": "Intepirdine - MINDSET", "stage": "Phase 3", "date": "09/30/2017"},
{"ticker": "AZRX", "drug": "MS1819-SD", "stage": "Phase 2", "date": "09/30/2017"},
{"ticker": "FCSC", "drug": "FCX-007", "stage": "Phase 1/2", "date": "09/30/2017"},
{"ticker": "GILD", "drug": "GS-0976", "stage": "Phase 2", "date": "09/30/2017"},
{"ticker": "GTXI", "drug": "Enobosarm", "stage": "Phase 2", "date": "09/30/2017"},
{"ticker": "RDHL", "drug": "BEKINDA", "stage": "Phase 2", "date": "09/30/2017"},
{"ticker": "VBLT", "drug": "VB-111", "stage": "Phase 3", "date": "09/30/2017"},
{"ticker": "VRX", "drug": "SAN-300", "stage": "Phase 2", "date": "09/30/2017"},
{"ticker": "ZGNX", "drug": "ZX008 - (Study 1)", "stage": "Phase 3", "date": "09/30/2017"},
{"ticker": "ZYNE", "drug": "ZYN002", "stage": "Phase 2", "date": "09/30/2017"},
{"ticker": "CATB", "drug": "CAT-1004", "stage": "Phase 2", "date": "10/04/2017"},
{"ticker": "BLUE", "drug": "Lenti-D - Starbeam", "stage": "Phase 2/3", "date": "10/05/2017"},
{"ticker": "CAPR", "drug": "CAP-1002 HOPE-Duchenne", "stage": "Phase 1/2", "date": "10/06/2017"},
{"ticker": "FLXN", "drug": "Zilretta - FX006", "stage": "PDUFA", "date": "10/06/2017"},
{"ticker": "FOLD", "drug": "ATB200", "stage": "Phase 1/2", "date": "10/06/2017"},
{"ticker": "SRPT", "drug": "Golodirsen - Exon 53", "stage": "Phase 1/2", "date": "10/07/2017"},
{"ticker": "MYL", "drug": "MYL-1401H", "stage": "PDUFA", "date": "10/09/2017"},
{"ticker": "ACRX", "drug": "ARX-04 (SAP303)", "stage": "PDUFA", "date": "10/12/2017"},
{"ticker": "ONCE", "drug": "Voretigene neparvovec (SPK-RPE65)", "stage": "PDUFA priority review", "date": "10/12/2017"},
{"ticker": "AERI", "drug": "Rhopressa", "stage": "PDUFA", "date": "10/13/2017"},
{"ticker": "FENC", "drug": "Sodium Thiosulphate", "stage": "Phase 3", "date": "10/14/2017"},
{"ticker": "NBIX", "drug": "INGREZZA", "stage": "PDUFA", "date": "10/14/2017"},
{"ticker": "AVEO", "drug": "TIVO-3 - tivozanib", "stage": "Phase 3", "date": "10/15/2017"},
{"ticker": "JNJ", "drug": "STELARA (USTEKINUMAB)", "stage": "PDUFA", "date": "10/15/2017"},
{"ticker": "ATRS", "drug": "Makena - auto injector", "stage": "PDUFA", "date": "10/17/2017"},
{"ticker": "LOXO", "drug": "LOXO-292", "stage": "Phase 1", "date": "10/18/2017"},
{"ticker": "ATRS", "drug": "VIBEX QuickShot", "stage": "PDUFA", "date": "10/20/2017"},
{"ticker": "EIGR", "drug": "Pegylated Interferon Lambda (LIMT HDV)", "stage": "Phase 2", "date": "10/20/2017"},
{"ticker": "JNJ", "drug": "SIMPONI ARIA", "stage": "PDUFA", "date": "10/21/2017"},
{"ticker": "JNJ", "drug": "SIMPONI ARIA", "stage": "PDUFA", "date": "10/21/2017"},
{"ticker": "ALXN", "drug": "Eculizumab", "stage": "PDUFA", "date": "10/23/2017"},
{"ticker": "AGEN", "drug": "Shingrix", "stage": "PDUFA", "date": "10/24/2017"},
{"ticker": "GSK", "drug": "Shingrix", "stage": "PDUFA", "date": "10/24/2017"},
{"ticker": "TSRO", "drug": "Rolapitant - intravenous (IV)", "stage": "PDUFA", "date": "10/25/2017"},
{"ticker": "JNJ", "drug": "XARELTO (rivaroxaban)", "stage": "PDUFA priority review", "date": "10/28/2017"},
{"ticker": "MNOV", "drug": "MN-166", "stage": "Phase 2b", "date": "10/28/2017"},
{"ticker": "EGRX", "drug": "Ready-to-dilute (RTD) Pemetrexed Injection", "stage": "PDUFA", "date": "10/30/2017"},
{"ticker": "DBVT", "drug": "Viaskin Peanut (PEPITES)", "stage": "Phase 3", "date": "10/31/2017"},
{"ticker": "PRTA", "drug": "PRX003", "stage": "Phase 1b", "date": "10/31/2017"},
{"ticker": "KERX", "drug": "Auryxia", "stage": "PDUFA", "date": "11/06/2017"},
{"ticker": "PFE", "drug": "Staphylococcus aureus vaccine", "stage": "PDUFA", "date": "11/07/2017"},
{"ticker": "BMY", "drug": "Sprycel (dasatinib)", "stage": "PDUFA priority review", "date": "11/09/2017"},
{"ticker": "DVAX", "drug": "HEPLISAV-B", "stage": "PDUFA", "date": "11/10/2017"},
{"ticker": "CALA", "drug": "CB-839 + nivolumab", "stage": "Phase 1/2", "date": "11/11/2017"},
{"ticker": "HRTX", "drug": "CINVANTI (HTX-019)", "stage": "PDUFA", "date": "11/12/2017"},
{"ticker": "ARDX", "drug": "Tenapanor (T3MPO-2)", "stage": "Phase 3", "date": "11/15/2017"},
{"ticker": "RARE", "drug": "rhGUS", "stage": "PDUFA priority review", "date": "11/16/2017"},
{"ticker": "KITE", "drug": "Axicabtagene ciloleucel (KTE-C19) - ZUMA-1", "stage": "PDUFA priority review", "date": "11/29/2017"},
{"ticker": "CLDX", "drug": "Glembatumumab vedotin, varlilumab, Opdivo or Keytruda", "stage": "Phase 2", "date": "11/30/2017"},
{"ticker": "AMGN", "drug": "Repatha", "stage": "PDUFA", "date": "12/02/2017"},
{"ticker": "MYL", "drug": "MYL-1401O - trastuzumab biosimilar", "stage": "PDUFA", "date": "12/03/2017"},
{"ticker": "GSK", "drug": "Dolutegravir + rilpivirine:", "stage": "PDUFA priority review", "date": "12/05/2017"},
{"ticker": "JNJ", "drug": "Rilpivirine and Dolutegravir", "stage": "PDUFA priority review", "date": "12/05/2017"},
{"ticker": "NVO", "drug": "Semaglutide", "stage": "PDUFA", "date": "12/05/2017"},
{"ticker": "ARGX", "drug": "ARGX-110", "stage": "Phase 2", "date": "12/09/2017"},
{"ticker": "BLUE", "drug": "LentiGlobin - HGB-206", "stage": "Phase 1/2", "date": "12/09/2017"},
{"ticker": "IMDZ", "drug": "G100", "stage": "Phase 2", "date": "12/09/2017"},
{"ticker": "SGEN", "drug": "ADCETRIS", "stage": "PDUFA priority review", "date": "12/16/2017"},
{"ticker": "ACRS", "drug": "A-101", "stage": "PDUFA", "date": "12/24/2017"},
{"ticker": "AGRX", "drug": "Twirla", "stage": "PDUFA", "date": "12/26/2017"},
{"ticker": "CORI", "drug": "Twirla", "stage": "PDUFA", "date": "12/26/2017"},
{"ticker": "VRX", "drug": "Luminesse", "stage": "PDUFA", "date": "12/27/2017"},
{"ticker": "AEZS", "drug": "Macimorelin Acetate - Macrilen", "stage": "PDUFA", "date": "12/30/2017"},
{"ticker": "ABBV", "drug": "Imbruvica - PHOENIX", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "ABBV", "drug": "Risankizumab", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "ABBV", "drug": "Elagolix", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "ABBV", "drug": "Risankizumab", "stage": "Phase 2b", "date": "12/31/2017"},
{"ticker": "ABBV", "drug": "Rova-T (TRINITY)", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "ADRO", "drug": "CRS-207 with pembrolizumab", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "ADXS", "drug": "Axalimogene filolisbac + durvalumab", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "ADXS", "drug": "Axalimogene filolisbac", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "AFMD", "drug": "AFM13 with Keytruda", "stage": "Phase 1b", "date": "12/31/2017"},
{"ticker": "AGN", "drug": "Cortisol Analog", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "ALKS", "drug": "ALKS 8700", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "ANAB", "drug": "ANB020", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "ANAB", "drug": "ANB020", "stage": "Phase 2a", "date": "12/31/2017"},
{"ticker": "ARDX", "drug": "RDX7675", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "ARGS", "drug": "rocapuldencel-T (AGS-003)", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "AST", "drug": "AST-OPC1 SCiSTAR", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "ATNM", "drug": "Actimab-A", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "ATNX", "drug": "Oraxol", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "AXON", "drug": "Intepirdine - HEADWAY-DLB", "stage": "Phase 2b", "date": "12/31/2017"},
{"ticker": "AXON", "drug": "Nelotanserin", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "AZN", "drug": "Tralokinumab (STRATOS2)", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "AZN", "drug": "Moxetumomab", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "AZN", "drug": "Durvalumab +/- tremelimumab (ARCTIC)", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "AZN", "drug": "Benralizumab", "stage": "PDUFA", "date": "12/31/2017"},
{"ticker": "BIIB", "drug": "BAN2401 (A\u03b2 mAb)", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "BIIB", "drug": "BG00011 (STX-100)", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "BLRX", "drug": "BL-8040 in combination with KEYTRUDA - COMBAT trial", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "BLRX", "drug": "BL-8040", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "BMY", "drug": "CM-459 \u2013 Opdivo", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "BMY", "drug": "CM-511 \u2013 Opdivo + Yervoy", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "BMY", "drug": "CM-227 \u2013 Opdivo + Yervoy", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "BOLD", "drug": "AT342 - VALENS", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "BOLD", "drug": "AT132 - ASPIRO", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "BPTH", "drug": "BP-1001", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "BTX", "drug": "AST-OPC1 - SCiStar", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "BYSI", "drug": "Plinabulin (Trial 106)", "stage": "Phase 2/3", "date": "12/31/2017"},
{"ticker": "BYSI", "drug": "Plinabulin (Trial 105)", "stage": "Phase 2/3", "date": "12/31/2017"},
{"ticker": "CALA", "drug": "CB-839 with paclitaxel", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "CBIO", "drug": "CB 2679d/ ISU304", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "CDTX", "drug": "CD101 IV - STRIVE", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "CELG", "drug": "REVLIMID - RELEVANCE", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "CELG", "drug": "REVLIMID - AUGMENT NHL-007", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "CELG", "drug": "Ozanimod - SUNBEAM", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "CELG", "drug": "OTEZLA - BCT-002 RELIEF", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "CELG", "drug": "ABRAXANE - PANC-003 apact", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "CELG", "drug": "ABRAXANE - NSCL-003 abound.sqm", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "CELG", "drug": "ABRAXANE - NSCL-003 abound.70+", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "CELG", "drug": "Ozanimod - RADIANCE", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "CELG", "drug": "OTEZLA", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "CELG", "drug": "GED-0301", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "CEMP", "drug": "Taksta - Fusidic acid", "stage": "Phase 2/3", "date": "12/31/2017"},
{"ticker": "CLRB", "drug": "CLR 131", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "CLSD", "drug": "Suprachoroidal CLS-TA - HULK", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "CPRX", "drug": "Firdapse", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "CRBP", "drug": "Anabasum (Resunab)", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "CRMD", "drug": "Neutrolin - LOCK-IT 100", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "CYTK", "drug": "Tirasemtiv - VITALITY", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "DARE", "drug": "CRLX301", "stage": "Phase 2a", "date": "12/31/2017"},
{"ticker": "DARE", "drug": "CRLX101, in combination with LYNPARZA", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "DARE", "drug": "CRLX101 and paclitaxel", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "DBVT", "drug": "Viaskin Peanut (REALISE)", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "DBVT", "drug": "Viaskin Milk", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "DCTH", "drug": "Melphalan Hepatic Delivery System (Melphalan HDS)", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "DMTX", "drug": "DTX301", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "DRRX", "drug": "POSIMIR - PERSIST 3", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "EARS", "drug": "AM-111 HEALOS", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "EGLT", "drug": "Egalet-002", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "EVOK", "drug": "Gimoti - EVK-001", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "EXEL", "drug": "XL184 cabozantinib (CELESTIAL)", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "EYEG", "drug": "EGP-437", "stage": "Phase 2b", "date": "12/31/2017"},
{"ticker": "EYEG", "drug": "EGP-437", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "FBIO", "drug": "CAEL\u2010101", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "FBIO", "drug": "Triplex vaccine", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "FLKS", "drug": "FLX-787", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "GALT", "drug": "GR-MD-02", "stage": "Phase 2b", "date": "12/31/2017"},
{"ticker": "GBT", "drug": "GBT440", "stage": "Phase 2a", "date": "12/31/2017"},
{"ticker": "GBT", "drug": "GBT440 HOPE-KIDS 1", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "GILD", "drug": "GS-9674", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "GNMX", "drug": "AEVI-002 (Anti-LIGHT mAb)", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "GSK", "drug": "anti-SAP mAb", "stage": "Phase 2b", "date": "12/31/2017"},
{"ticker": "GSK", "drug": "GSK 165", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "GSK", "drug": "Nucala", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "GSK", "drug": "GSK 166", "stage": "Phase 2b", "date": "12/31/2017"},
{"ticker": "GSK", "drug": "GSK 165", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "HALO", "drug": "PEGPH20 in combination with KEYTRUDA", "stage": "Phase 1b", "date": "12/31/2017"},
{"ticker": "IMRN", "drug": "IMM-124E", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "IONS", "drug": "IONIS-HTT Rx", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "IRWD", "drug": "IW-1973", "stage": "Phase 2a", "date": "12/31/2017"},
{"ticker": "IRWD", "drug": "IW-1973", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "KDMN", "drug": "KD025", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "KDMN", "drug": "KD025", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "KITE", "drug": "Axicabtagene ciloleucel - KTE-C19 (ZUMA-6)", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "KMDA", "drug": "Alpha-1 Antitrypsin (AAT)", "stage": "Phase 2/3", "date": "12/31/2017"},
{"ticker": "LLY", "drug": "Flortaucipir F 18 (Tau imaging agent)", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "LLY", "drug": "Alimta + Keytruda (MK-3475-189/KEYNOTE-189)", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "LLY", "drug": "Abemaciclib - JUNIPER", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "LOXO", "drug": "Larotrectinib (LOXO-101)", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "MBVX", "drug": "MVT-1075", "stage": "Phase 1", "date": "12/31/2017"},
{"ticker": "MCRB", "drug": "SER-287", "stage": "Phase 1b", "date": "12/31/2017"},
{"ticker": "MDGL", "drug": "MGL-3196", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "MESO", "drug": "MSC-100-IV", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "MRK", "drug": "(MK-3475-189/KEYNOTE-189)", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "MRK", "drug": "Ertugliflozin", "stage": "PDUFA", "date": "12/31/2017"},
{"ticker": "MRNS", "drug": "Ganaxolone", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "MRSN", "drug": "XMT1522", "stage": "Phase 1", "date": "12/31/2017"},
{"ticker": "MRTX", "drug": "Mocetinostat and durvalumab", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "MRTX", "drug": "Glesatinib (MGCD265)", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "MRUS", "drug": "MCLA-128", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "MTFB", "drug": "Iclaprim - REVIVE-2", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "NBIX", "drug": "Elagolix", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "NKTR", "drug": "Inhaled Amikacin Solution (BAY41-6551T)", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "NLNK", "drug": "Indoximod + chemotherapy", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "NLNK", "drug": "Indoximod + temozolomide", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "NLNK", "drug": "Indoximod + gemcitabine and nab-paclitaxel", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "NVAX", "drug": "NanoFlu vaccine", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "NVS", "drug": "LEE011: MONALEESA-3", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "OCRX", "drug": "OCR-002", "stage": "Phase 2a", "date": "12/31/2017"},
{"ticker": "OGEN", "drug": "AG013", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "ONCS", "drug": "ImmunoPulse IL-12", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "ONTX", "drug": "IV Rigosertib - INSPIRE", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "PBYI", "drug": "Neratinib monotherapy with high dose loperamide prophylaxis - CONTROL", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "PFE", "drug": "Xeljanz", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "PFE", "drug": "Ertugliflozin", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "PFE", "drug": "BOSULIF", "stage": "PDUFA priority review", "date": "12/31/2017"},
{"ticker": "PHMMF", "drug": "Zepsyre(PM1183)", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "PLX", "drug": "OPRX-106", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "PSTI", "drug": "PLX-PAD (stem cells)", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "PTI", "drug": "PTI-428", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "PULM", "drug": "PUR0200", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "RDUS", "drug": "Elacestrant", "stage": "Phase 2b", "date": "12/31/2017"},
{"ticker": "REGN", "drug": "EYLEA + nesvacumab", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "REGN", "drug": "EYLEA + nesvacumab", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "RETA", "drug": "Bardoxolone methyl - LARIAT", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "RETA", "drug": "Omaveloxolone - MOTOR", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "RETA", "drug": "Omaveloxolone - REVEAL", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "RGLS", "drug": "RG-012", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "RGNX", "drug": "RGX-501", "stage": "Phase 1/2", "date": "12/31/2017"},
{"ticker": "RIGL", "drug": "Fostamatinib", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "RNN", "drug": "Supinoxin", "stage": "Phase 2a", "date": "12/31/2017"},
{"ticker": "RNN", "drug": "RX-3117", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "RNN", "drug": "Archexin", "stage": "Phase 2a", "date": "12/31/2017"},
{"ticker": "RVNC", "drug": "RT002 - SAKURA 2", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "RVNC", "drug": "RT002", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "RVNC", "drug": "RT002 - SAKURA 1", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "RXDX", "drug": "RXDX-105", "stage": "Phase 1b", "date": "12/31/2017"},
{"ticker": "RXDX", "drug": "STARTRK-2 entrectinib", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "RXII", "drug": "RXI-109-1402", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "RXII", "drug": "Samcyprone - RXI-SCP-1502", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "SAGE", "drug": "Brexanolone - SAGE-547 (202C)", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "SAGE", "drug": "SAGE-217", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "SAGE", "drug": "SAGE-217", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "SAGE", "drug": "SAGE-217", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "SAGE", "drug": "Brexanolone - SAGE-547 (202B)", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "SAGE", "drug": "SAGE-217", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "SNDX", "drug": "E2112", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "SPPI", "drug": "Poziotinib", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "SPPI", "drug": "Poziotinib", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "STML", "drug": "SL-401", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "STML", "drug": "SL-401", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "STML", "drug": "SL-401", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "SVRA", "drug": "AIR001", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "TCON", "drug": "TRC105 and Inlyta", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "TCON", "drug": "TRC105", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "TCON", "drug": "TRC102", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "TSRO", "drug": "Niraparib - (QUADRA trial)", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "VKTX", "drug": "VK5211", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "VNDA", "drug": "HETLIOZ (tasimelteon)", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "VRTX", "drug": "CTP-656", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "VRTX", "drug": "Tezacaftor (VX-661) / ivacaftor", "stage": "Phase 3", "date": "12/31/2017"},
{"ticker": "XBIT", "drug": "Xilonix", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "XLRN", "drug": "ACE-083", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "XNCR", "drug": "XmAb5871", "stage": "Phase 2", "date": "12/31/2017"},
{"ticker": "XENT", "drug": "RESOLVE steroid-releasing implant", "stage": "PDUFA", "date": "01/07/2018"},
{"ticker": "EIGR", "drug": "Ubenimex - LIBERTY", "stage": "Phase 2", "date": "01/08/2018"},
{"ticker": "ARGX", "drug": "ARGX-110", "stage": "Phase 1/2", "date": "01/09/2018"},
{"ticker": "LLY", "drug": "Abemaciclib - MONARCH 1 and 2", "stage": "PDUFA priority review", "date": "01/10/2018"},
{"ticker": "AXSM", "drug": "AXS-02 CREATE-1", "stage": "Phase 3", "date": "01/15/2018"},
{"ticker": "AXSM", "drug": "AXS-02 COAST-1", "stage": "Phase 3", "date": "01/15/2018"},
{"ticker": "SGYP", "drug": "Trulance (plecanatide)", "stage": "PDUFA", "date": "01/24/2018"},
{"ticker": "AAAP", "drug": "Lutathera", "stage": "PDUFA", "date": "01/26/2018"},
{"ticker": "PFE", "drug": "Talazoparib", "stage": "Phase 3", "date": "01/31/2018"},
{"ticker": "AZN", "drug": "Acalabrutinib", "stage": "PDUFA priority review", "date": "02/01/2018"},
{"ticker": "AMAG", "drug": "Feraheme", "stage": "PDUFA", "date": "02/02/2018"},
{"ticker": "PTLA", "drug": "Andexanet alfa", "stage": "PDUFA", "date": "02/02/2018"},
{"ticker": "AMGN", "drug": "XGEVA", "stage": "PDUFA", "date": "02/03/2018"},
{"ticker": "LPCN", "drug": "LPCN 1021", "stage": "PDUFA", "date": "02/08/2018"},
{"ticker": "GILD", "drug": "Bictegravir/F/TAF", "stage": "PDUFA priority review", "date": "02/12/2018"},
{"ticker": "AMAG", "drug": "Makena - auto injector", "stage": "PDUFA", "date": "02/14/2018"},
{"ticker": "APRI", "drug": "Vitaros", "stage": "PDUFA", "date": "02/17/2018"},
{"ticker": "KMPH", "drug": "KP201/APAP", "stage": "PDUFA", "date": "02/23/2018"},
{"ticker": "LJPC", "drug": "LJPC-501", "stage": "PDUFA priority review", "date": "02/28/2018"},
{"ticker": "MDGL", "drug": "MGL-3196", "stage": "Phase 2", "date": "02/28/2018"},
{"ticker": "SRNE", "drug": "ZTlido (lidocaine patch 1.8%)", "stage": "PDUFA", "date": "02/28/2018"},
{"ticker": "VRTX", "drug": "Tezacaftor (VX-661) / ivacaftor", "stage": "PDUFA priority review", "date": "02/28/2018"},
{"ticker": "OTIC", "drug": "OTIPRIO", "stage": "Phase 3", "date": "03/02/2018"},
{"ticker": "BMY", "drug": "Opdivo -  4 week applications", "stage": "PDUFA", "date": "03/05/2018"},
{"ticker": "PFE", "drug": "Xeljanz", "stage": "PDUFA", "date": "03/13/2018"},
{"ticker": "ABIO", "drug": "Gencaro - GENETIC-AF trial", "stage": "Phase 2b", "date": "03/31/2018"},
{"ticker": "ACOR", "drug": "Tozadenant", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "AIMT", "drug": "AR101", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "ANTH", "drug": "Sollpura - RESULT", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "ARGX", "drug": "ARGX-113", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "ARNA", "drug": "APD371", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "ARNA", "drug": "Etrasimod", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "AXON", "drug": "Nelotanserin", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "AXSM", "drug": "AXS-05 STRIDE-1", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "AZN", "drug": "Brilinta (THEMIS)", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "BHVN", "drug": "BHV-4157 Trigriluzole", "stage": "Phase 2/3", "date": "03/31/2018"},
{"ticker": "CLBS", "drug": "CLBS03", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "CLSD", "drug": "Suprachoroidal CLS-TA - PEACHTREE", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "CORI", "drug": "Corplex Donepezil", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "CORT", "drug": "CORT125134", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "CYTK", "drug": "CK-2127107", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "DERM", "drug": "Olumacostat glasaretil (DRM01)", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "EARS", "drug": "Keyzilen (AM-101) - TACTT3", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "ESPR", "drug": "Bempedoic Acid - 1002-039", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "FGEN", "drug": "Pamrevlumab (FG-3019)", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "GALE", "drug": "NeuVax in combination with Herceptin", "stage": "Phase 2b", "date": "03/31/2018"},
{"ticker": "GEMP", "drug": "Gemcabene - INDIGO-1", "stage": "Phase 2b", "date": "03/31/2018"},
{"ticker": "GERN", "drug": "Imetelstat - IMbarkStudy", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "GSK", "drug": "Dolutegravir + lamivudine (GEMINI 1)", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "GTHX", "drug": "Trilaciclib", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "GTHX", "drug": "Trilaciclib", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "GTHX", "drug": "Trilaciclib", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "GWPH", "drug": "GWP42006 (CBDV)", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "MBIO", "drug": "MB-102", "stage": "Phase 1", "date": "03/31/2018"},
{"ticker": "MBIO", "drug": "MB-101", "stage": "Phase 1", "date": "03/31/2018"},
{"ticker": "MCRB", "drug": "SER-262", "stage": "Phase 1b", "date": "03/31/2018"},
{"ticker": "MEIP", "drug": "Pracinostat in combination with Vidaza", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "MESO", "drug": "MPC-150-IM", "stage": "Phase 2b", "date": "03/31/2018"},
{"ticker": "MYOK", "drug": "MYK-461 - PIONEER-HCM", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "OBSV", "drug": "OBE001 - IMPLANT2", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "OHRP", "drug": "OHR-102 (MAKO)", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "PFE", "drug": "Tanezumab", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "PFE", "drug": "Tanezumab", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "PTGX", "drug": "PTG-100", "stage": "Phase 2b", "date": "03/31/2018"},
{"ticker": "REGN", "drug": "Praluent (alirocumab) ODYSSEY OUTCOMES", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "RXII", "drug": "RXI-109-1501", "stage": "Phase 1/2", "date": "03/31/2018"},
{"ticker": "SGMO", "drug": "SB-318", "stage": "Phase 1/2", "date": "03/31/2018"},
{"ticker": "SGMO", "drug": "SB-FIX", "stage": "Phase 1/2", "date": "03/31/2018"},
{"ticker": "SGMO", "drug": "SB-913", "stage": "Phase 1/2", "date": "03/31/2018"},
{"ticker": "SMMT", "drug": "Ezutromid", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "SNY", "drug": "SAR439684 (PD-1)", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "SNY", "drug": "Praluent (alirocumab) ODYSSEY OUTCOMES", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "SPHS", "drug": "Topsalysin (PRX302)", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "SPPI", "drug": "SPI-2012 (ROLONTIS)", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "TCON", "drug": "TRC105 and Nexavar", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "TTPH", "drug": "Eravacycline (TP-434) - IGNITE3", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "VICL", "drug": "VCL-HB01 HSV-2 Therapeutic Vaccine", "stage": "Phase 2", "date": "03/31/2018"},
{"ticker": "VICL", "drug": "ASP0113 Vaccine", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "VTVT", "drug": "Azeliragon - STEADFAST", "stage": "Phase 3", "date": "03/31/2018"},
{"ticker": "RIGL", "drug": "Fostamatinib", "stage": "PDUFA", "date": "04/17/2018"},
{"ticker": "AMGN", "drug": "KYPROLIS (ENDEAVOR)", "stage": "PDUFA", "date": "04/30/2018"},
{"ticker": "KPTI", "drug": "Selinexor - STORM", "stage": "Phase 2b", "date": "04/30/2018"},
{"ticker": "NBRV", "drug": "Lefamulin - LEAP 2", "stage": "Phase 3", "date": "04/30/2018"},
{"ticker": "AMGN", "drug": "Erenumab", "stage": "PDUFA", "date": "05/17/2018"},
{"ticker": "NVS", "drug": "Erenumab", "stage": "PDUFA", "date": "05/17/2018"},
{"ticker": "AGN", "drug": "ATOGEPANT", "stage": "Phase 2b", "date": "06/30/2018"},
{"ticker": "AGN", "drug": "UBROGEPANT", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "ALRN", "drug": "ALRN-6924", "stage": "Phase 2a", "date": "06/30/2018"},
{"ticker": "ALXN", "drug": "ALXN1210", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "AMGN", "drug": "ABP 798", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "ANAB", "drug": "ANB020", "stage": "Phase 2a", "date": "06/30/2018"},
{"ticker": "ARRY", "drug": "Binimetinib - COLUMBUS", "stage": "PDUFA", "date": "06/30/2018"},
{"ticker": "AVIR", "drug": "BTA074 5% topical gel", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "AZN", "drug": "Lynparza", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "AZN", "drug": "Durvalumab +/- tremelimumab (MYSTIC)", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "AZN", "drug": "Durvalumab +/- tremelimumab (KESTREL)", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "AZN", "drug": "Durvalumab +/- tremelimumab (EAGLE)", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "BHVN", "drug": "Rimegepant", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "BMY", "drug": "CM-651 \u2013 Opdivo + Yervoy", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "BMY", "drug": "CM-451 \u2013 Opdivo + Yervoy", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "BMY", "drug": "CM-331\u2013 Opdivo", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "BMY", "drug": "CM-078 \u2013 Opdivo", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "BMY", "drug": "CM-548 - Opdivo+SOC", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "CLDX", "drug": "Glembatumumab vedotin", "stage": "Phase 2b", "date": "06/30/2018"},
{"ticker": "CLSD", "drug": "Suprachoroidal CLS-TA - TYBEE", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "CNAT", "drug": "Emricasan", "stage": "Phase 2b", "date": "06/30/2018"},
{"ticker": "CPRX", "drug": "Firdapse", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "CTIC", "drug": "PIXUVRI - PIX306 Trial", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "EIGR", "drug": "Ubenimex - ULTRA", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "ESPR", "drug": "Bempedoic acid - CLEAR LDL-C Lowering Program 1002-046, 1002-047 and 1002-048", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "ESPR", "drug": "Bempedoic acid (ETC-1002-040) - Clear Harmony", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "FBIO", "drug": "CEVA101", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "FBIO", "drug": "Pepvax vaccine", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "FBIO", "drug": "IV Tramadol", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "FLKS", "drug": "FLX-787", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "FOMX", "drug": "FMX101 - FX2017-22", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "GLMD", "drug": "Aramchol - ARREST", "stage": "Phase 2b", "date": "06/30/2018"},
{"ticker": "GTHX", "drug": "G1T38 plus Faslodex", "stage": "Phase 1b", "date": "06/30/2018"},
{"ticker": "IDRA", "drug": "IMO-8400", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "JNCE", "drug": "JTX-2011", "stage": "Phase 1/2", "date": "06/30/2018"},
{"ticker": "JNJ", "drug": "Esketamine", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "KURA", "drug": "Tipifarnib", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "KURA", "drug": "Tipifarnib", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "MACK", "drug": "MM-141 - CARRIE", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "MDWD", "drug": "NexoBrid", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "MTNB", "drug": "MAT2501", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "NVCR", "drug": "Tumor Treating Fields (TTFields) STELLAR", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "OCUL", "drug": "OTX-TP", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "PBYI", "drug": "Neratinib", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "PRTA", "drug": "NEOD001 PRONTO", "stage": "Phase 2b", "date": "06/30/2018"},
{"ticker": "RNN", "drug": "RX-3117 in combination with Abraxane", "stage": "Phase 2a", "date": "06/30/2018"},
{"ticker": "SBBP", "drug": "COR-003 (levoketoconazole) - SONICS", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "SNGX", "drug": "SGX301 (synthetic hypericin)", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "SVRA", "drug": "Aironite - INDIE", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "TBPH", "drug": "TD-9855", "stage": "Phase 2a", "date": "06/30/2018"},
{"ticker": "TGTX", "drug": "TG-1101 and TGR-1202 - UNITY-CLL study", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "TNXP", "drug": "TNX-102 SL", "stage": "Phase 3", "date": "06/30/2018"},
{"ticker": "TOCA", "drug": "Toca 511 & Toca FC", "stage": "Phase 2/3", "date": "06/30/2018"},
{"ticker": "VKTX", "drug": "VK2809", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "VNDA", "drug": "Tradipitant", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "ZFGN", "drug": "ZGN-1061", "stage": "Phase 2", "date": "06/30/2018"},
{"ticker": "ALNY", "drug": "Givosiran", "stage": "Phase 3", "date": "07/31/2018"},
{"ticker": "CELG", "drug": "Luspatercept - BELIEVE", "stage": "Phase 3", "date": "07/31/2018"},
{"ticker": "CELG", "drug": "Luspatercept - MEDALIST", "stage": "Phase 3", "date": "07/31/2018"},
{"ticker": "EBIO", "drug": "Vicinium", "stage": "Phase 3", "date": "07/31/2018"},
{"ticker": "FOMX", "drug": "FMX103", "stage": "Phase 3", "date": "07/31/2018"},
{"ticker": "GNMX", "drug": "AEVI-001 (NFC-1)", "stage": "Phase 2", "date": "07/31/2018"},
{"ticker": "LLY", "drug": "Ramucirumab", "stage": "Phase 3", "date": "07/31/2018"},
{"ticker": "OBSV", "drug": "OBE2109 - EDELWEISS", "stage": "Phase 2b", "date": "07/31/2018"},
{"ticker": "RGLS", "drug": "RG-012 - HERA", "stage": "Phase 2", "date": "07/31/2018"},
{"ticker": "SCYX", "drug": "SCY-078 - oral", "stage": "Phase 2", "date": "07/31/2018"},
{"ticker": "VTL", "drug": "VTI-308", "stage": "Phase 3", "date": "07/31/2018"},
{"ticker": "XLRN", "drug": "Luspatercept - MEDALIST", "stage": "Phase 3", "date": "07/31/2018"},
{"ticker": "XLRN", "drug": "Luspatercept - BELIEVE", "stage": "Phase 3", "date": "07/31/2018"},
{"ticker": "AGTC", "drug": "rAAV-hRS1", "stage": "Phase 1/2", "date": "09/30/2018"},
{"ticker": "AMRN", "drug": "Vascepa REDUCE-IT outcomes trial", "stage": "\u2013", "date": "09/30/2018"},
{"ticker": "AQXP", "drug": "AQX-1125 LEADERSHIP", "stage": "Phase 3", "date": "09/30/2018"},
{"ticker": "HSGX", "drug": "NeoCart", "stage": "Phase 3", "date": "09/30/2018"},
{"ticker": "SBBP", "drug": "COR-003 (levoketoconazole) - LOGICS", "stage": "Phase 3", "date": "09/30/2018"},
{"ticker": "CNCE", "drug": "AVP-786", "stage": "Phase 3", "date": "09/30/2018"},
{"ticker": "AGLE", "drug": "AEB1102", "stage": "Phase 1/2", "date": "12/31/2018"},
{"ticker": "AGN", "drug": "Brazikumab", "stage": "Phase 2b", "date": "12/31/2018"},
{"ticker": "AGN", "drug": "Cariprazine", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "AGN", "drug": "ABICIPAR", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "AKBA", "drug": "Vadadustat - TRILO2GY", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "AKBA", "drug": "Vadadustat - FO2RWARD", "stage": "Phase 2", "date": "12/31/2018"},
{"ticker": "ALDX", "drug": "ADX-102", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "ALDX", "drug": "ADX-102", "stage": "Phase 2", "date": "12/31/2018"},
{"ticker": "ALKS", "drug": "ALKS 3831 - ENLIGHTEN-2", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "ALXN", "drug": "Eculizumab", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "ANIK", "drug": "Cingal", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "ARGX", "drug": "ARGX-113", "stage": "Phase 2", "date": "12/31/2018"},
{"ticker": "AZN", "drug": "Dapagliflozin - DECLARE", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "AZN", "drug": "Benralizumab - TERRANOVA", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "AZN", "drug": "Farxiga - DECLARE", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "AZN", "drug": "Selumetinib - ASTRA", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "AZN", "drug": "Roxadustat - ANDES", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "AZN", "drug": "PT010", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "AZN", "drug": "Durvalumab +/- tremelimumab (NEPTUNE)", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "AZN", "drug": "Durvalumab +/- tremelimumab (DANUBE)", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "AZN", "drug": "Anifrolumab", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "BIIB", "drug": "Raxatrigine - BIIB074 (Nav1.7 inhibitor)", "stage": "Phase 2", "date": "12/31/2018"},
{"ticker": "BLPH", "drug": "INOpulse delivery device", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "BLRX", "drug": "BL-8040", "stage": "Phase 2b", "date": "12/31/2018"},
{"ticker": "BMY", "drug": "CM-602 \u2013 Opdivo + Elo + SOC", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "BYSI", "drug": "Plinabulin", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "CELG", "drug": "REVLIMID - ROBUST", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "CELG", "drug": "MM-007 OPTIMISMM", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "CELG", "drug": "Ozanimod - TRUE NORTH", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "CELG", "drug": "GED-0301 (CD-003)", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "CELG", "drug": "GED-0301 (CD-002)", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "CELG", "drug": "Oral Azacitidine - CC-486-AML-001", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "CELG", "drug": "ABRAXANE - IMpower 131 ( I/O Combo)", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "CELG", "drug": "ABRAXANE - IMpower 130 ( I/O Combo)", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "CELG", "drug": "ABRAXANE - IMPassion ( I/O Combo)", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "CFRX", "drug": "CF-301", "stage": "Phase 2", "date": "12/31/2018"},
{"ticker": "CNAT", "drug": "Emricasan", "stage": "Phase 2", "date": "12/31/2018"},
{"ticker": "CNCE", "drug": "CTP-543", "stage": "Phase 2a", "date": "12/31/2018"},
{"ticker": "EARS", "drug": "AM-111 ASSENT", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "EPZM", "drug": "Tazemetostat", "stage": "Phase 2", "date": "12/31/2018"},
{"ticker": "FGEN", "drug": "Roxadustat - ANDES", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "GEMP", "drug": "Gemcabene - AZURE-1", "stage": "Phase 2", "date": "12/31/2018"},
{"ticker": "GSK", "drug": "Closed Triple - CAPTAIN", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "GWPH", "drug": "Epidiolex", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "IMGN", "drug": "Kadcyla (KATHERINE).", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "IMRN", "drug": "IMM-529", "stage": "Phase 1/2", "date": "12/31/2018"},
{"ticker": "INCY", "drug": "Epacadostat with Keytruda - ECHO-301", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "INVA", "drug": "Closed Triple", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "IOVA", "drug": "LN-145", "stage": "Phase 2", "date": "12/31/2018"},
{"ticker": "JNJ", "drug": "STELARA (USTEKINUMAB)", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "JNJ", "drug": "DARZALEX (Daratumumab)", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "KALA", "drug": "KPI\u2011121 0.25%", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "KALA", "drug": "KPI\u2011121 0.25%", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "KITE", "drug": "Axicabtagene ciloleucel - KTE-C19 (ZUMA-2)", "stage": "Phase 2", "date": "12/31/2018"},
{"ticker": "KITE", "drug": "Axicabtagene ciloleucel - KTE-C19 (ZUMA-3)", "stage": "Phase 1/2", "date": "12/31/2018"},
{"ticker": "KITE", "drug": "Axicabtagene ciloleucel - KTE-C19 (ZUMA-4)", "stage": "Phase 1/2", "date": "12/31/2018"},
{"ticker": "KPTI", "drug": "Selinexor - SADAL", "stage": "Phase 2b", "date": "12/31/2018"},
{"ticker": "MACK", "drug": "MM-121", "stage": "Phase 2", "date": "12/31/2018"},
{"ticker": "MBRX", "drug": "Annamycin", "stage": "Phase 1/2", "date": "12/31/2018"},
{"ticker": "MRK", "drug": "Epacadostat with Keytruda - ECHO-301", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "NVS", "drug": "QVM149", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "NVS", "drug": "LEE011: MONALEESA-7", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "NVS", "drug": "Entresto - PIONEER", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "NVS", "drug": "Entresto - PARAGON", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "NVS", "drug": "AIN457 (Cosentyx)", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "OBSV", "drug": "OBE022 - PROLONG", "stage": "Phase 2a", "date": "12/31/2018"},
{"ticker": "PFE", "drug": "Tanezumab", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "PLX", "drug": "PRX-102", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "PULM", "drug": "PUR1800", "stage": "Phase 2", "date": "12/31/2018"},
{"ticker": "RETA", "drug": "Bardoxolone methyl - CATALYST", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "RIGL", "drug": "Fostamatinib", "stage": "Phase 2", "date": "12/31/2018"},
{"ticker": "SGEN", "drug": "ADCETRIS in combination with chemotherapy - ECHELON-2", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "SNNA", "drug": "SNA-001", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "SNNA", "drug": "SNA-001", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "SVRA", "drug": "Molgradex", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "TBPH", "drug": "Closed Triple - CAPTAIN", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "UTHR", "drug": "Esuberaprost - BEAT", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "UTHR", "drug": "Orenitram", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "VNDA", "drug": "HETLIOZ (tasimelteon)", "stage": "Phase 3", "date": "12/31/2018"},
{"ticker": "VRNA", "drug": "RPL554", "stage": "Phase 2b", "date": "12/31/2018"},
{"ticker": "CLSN", "drug": "ThermoDox - OPTIMA", "stage": "Phase 3", "date": "03/31/2019"},
{"ticker": "GSK", "drug": "Danirixin", "stage": "Phase 2b", "date": "03/31/2019"},
{"ticker": "PRTO", "drug": "Vonapanitase (PRT-201) PATENCY-2", "stage": "Phase 3", "date": "03/31/2019"},
{"ticker": "XNCR", "drug": "XmAb5871", "stage": "Phase 2", "date": "03/31/2019"},
{"ticker": "ABBV", "drug": "ABBV-8E12", "stage": "Phase 2", "date": "06/30/2019"},
{"ticker": "ATNM", "drug": "Iomab-B", "stage": "Phase 3", "date": "06/30/2019"},
{"ticker": "BMY", "drug": "CM-568 - Opdivo + Yervoy", "stage": "Phase 2", "date": "06/30/2019"},
{"ticker": "CNAT", "drug": "Emricasan", "stage": "Phase 2", "date": "06/30/2019"},
{"ticker": "FBIO", "drug": "CEVA101", "stage": "Phase 2", "date": "06/30/2019"},
{"ticker": "GBT", "drug": "GBT440 - HOPE", "stage": "Phase 3", "date": "06/30/2019"},
{"ticker": "GSK", "drug": "Tapinarof", "stage": "Phase 3", "date": "06/30/2019"},
{"ticker": "GSK", "drug": "Inhaled PI3K\u03b4 inhibitor", "stage": "Phase 2b", "date": "06/30/2019"},
{"ticker": "ICPT", "drug": "Obeticholic acid (OCA) - REGENERATE", "stage": "Phase 3", "date": "06/30/2019"},
{"ticker": "TBPH", "drug": "Telavancin", "stage": "Phase 3", "date": "06/30/2019"},
{"ticker": "AKBA", "drug": "Vadadustat - INNO2VATE", "stage": "Phase 3", "date": "07/31/2019"},
{"ticker": "AKBA", "drug": "Vadadustat - PRO2TECT", "stage": "Phase 3", "date": "07/31/2019"},
{"ticker": "ABBV", "drug": "Venetoclax", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "AFMD", "drug": "AFM13", "stage": "Phase 2", "date": "12/31/2019"},
{"ticker": "AGN", "drug": "RAPASTINEL", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "ALNY", "drug": "Inclisiran", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "ALNY", "drug": "Fitusiran (ATLAS)", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "AZN", "drug": "AZD3293", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "CELG", "drug": "REVLIMID - MAGNIFY NHL-010", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "CHMA", "drug": "Mycapssa - OPTIMAL", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "CNAT", "drug": "Emricasan", "stage": "Phase 2b", "date": "12/31/2019"},
{"ticker": "CRBP", "drug": "Anabasum (Resunab)", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "GSK", "drug": "Mepolizumab - SYNAPSE", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "IMGN", "drug": "Kadcyla (KAITLIN)", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "JNJ", "drug": "INVOKANA - CREDENCE", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "JNJ", "drug": "DARZALEX (Daratumumab)", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "KPTI", "drug": "Selinexor - SEAL", "stage": "Phase 2/3", "date": "12/31/2019"},
{"ticker": "KPTI", "drug": "Selinexor - BOSTON", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "LLY", "drug": "AZD3293", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "MDCO", "drug": "Inclisiran", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "MRK", "drug": "MK-8931 (019) - Verubecestat", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "NVS", "drug": "QAW039 (fevipiprant)", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "NVS", "drug": "OMB157 (ofatumumab)", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "NVS", "drug": "Entresto - PARADISE", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "RETA", "drug": "Bardoxolone methyl - CARDINAL", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "SNY", "drug": "Fitusiran (ATLAS)", "stage": "Phase 3", "date": "12/31/2019"},
{"ticker": "ABBV", "drug": "ABBV-8E12", "stage": "Phase 2", "date": "06/30/2020"},
{"ticker": "OBSV", "drug": "OBE2109 - PRIMROSE", "stage": "Phase 3", "date": "06/30/2020"},
{"ticker": "AGN", "drug": "RELAMORELIN", "stage": "Phase 3", "date": "12/31/2020"},
{"ticker": "CELG", "drug": "REVLIMID - MAGNIFY NHL-008", "stage": "Phase 3", "date": "12/31/2020"},
{"ticker": "CHMA", "drug": "Mycapssa - MPOWERED", "stage": "Phase 3", "date": "12/31/2020"},
{"ticker": "GSK", "drug": "Daprodustat - ASCEND-D", "stage": "Phase 3", "date": "12/31/2020"},
{"ticker": "INCY", "drug": "Ruxolitinib - REACH 2", "stage": "Phase 3", "date": "12/31/2020"},
{"ticker": "NVCR", "drug": "Tumor Treating Fields (TTFields) METIS", "stage": "Phase 3", "date": "12/31/2020"},
{"ticker": "NVS", "drug": "Ruxolitinib - REACH 2", "stage": "Phase 3", "date": "12/31/2020"},
{"ticker": "PFE", "drug": "XTANDI", "stage": "Phase 3", "date": "12/31/2020"},
{"ticker": "PFE", "drug": "XTANDI (EMBARK)", "stage": "Phase 3", "date": "06/30/2021"},
{"ticker": "NVCR", "drug": "Tumor Treating Fields (TTFields) LUNAR", "stage": "Phase 3", "date": "12/31/2021"},
{"ticker": "AMGN", "drug": "CNP 520", "stage": "Phase 2/3", "date": "12/31/2023"},
{"ticker": "NVS", "drug": "CNP 520", "stage": "Phase 2/3", "date": "12/31/2023"}
]